NCT07321665 Effects of Physical Activity and Fitness, Cardiovascular- and Psychosocial Health on Medically Assisted Reproduction
| NCT ID | NCT07321665 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Infertility, Female |
| Study Type | OBSERVATIONAL |
| Enrollment | 115 participants |
| Start Date | 2026-01-16 |
| Primary Completion | 2030-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 115 participants in total. It began in 2026-01-16 with a primary completion date of 2030-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective observational study aims to investigate the association between physical activity and clinical pregnancy rates in women undergoing medically assisted reproduction. Additionally, it evaluates how cardiorespiratory fitness, cardiovascular health, psychosocial factors, sleep quality, stress, and cognitive function relate to reproductive outcomes.
Eligibility Criteria
Inclusion Criteria: * Voluntary written informed consent of the participant has been obtained prior to any screening procedures * Age 18-43 * Planning to undergo MAR (eg, IUI, IVF, ICSI) - Physically able to cycle for cardiopulmonary exercise testing (CPET) Exclusion Criteria: * Any reduction in general state of health preventing from performing hormonal stimulation for MAR * Absolute and relative contraindications for cardiopulmonary exercise testing (CPET) - No pregnancy at initial screening - Current illicit drug abuse including daily marijuana and CBD consumption (alcohol ≤2 drinks per day allowed) * Any kind of severe chronic disease (e.g. severe heart failure, active cancer disease) * Severe renal impairment (e.g. estimated glomerular filtration rate \<30 ml/min/m2) * Known liver cirrhosis or other severe liver impairment * Uncontrolled dysthyroidism * Uncontrolled hypertension * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, etc.
Contact & Investigator
James Geiger
STUDY CHAIR
University Hospital of Basel
Frequently Asked Questions
Who can join the NCT07321665 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 43 Years, studying Infertility, Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07321665 currently recruiting?
Yes, NCT07321665 is actively recruiting participants. Contact the research team at james.geiger@usb.ch for enrollment information.
Where is the NCT07321665 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT07321665 clinical trial?
NCT07321665 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is James Geiger at University Hospital of Basel. The trial plans to enroll 115 participants.